(8) reported moderate increase in plasma concentrations of proteins related to endothelial function (VCAM-1, intercellular adhesion molecules and E-selectin) persisting for at least three months after the initial doses of both adenovirus and mRNA COVID-19 vaccines. The gene discussed is VCAM1; the disease is COVID-19.